BRACCO DIAGNOSTICS INC FDA Inspection Record

FEI 1000307800 · Inspections, Form 483s, warning letters and import refusals

BRACCO DIAGNOSTICS INC is an FDA-registered facility (FEI 1000307800) located in Princeton, NJ, US. Registered operations: MANUFACTURE. RegDataLab tracks 7 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Nov 27, 2024: Voluntary Action Indicated (VAI)
Inspections on record
7 (1 OAI, 6 VAI)
Last OAI inspection
Jun 13, 2013
Warning letters
1 listed by FDA for this FEI, latest Jan 31, 2012
Recalls as the recalling firm
15, latest Mar 8, 2018

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 27, 2024Voluntary Action Indicated (VAI)Failure to develop written procedures (21 CFR 314.80(b))
Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Jun 5, 2017Voluntary Action Indicated (VAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
May 30, 2014Voluntary Action Indicated (VAI)Written control procedures (21 CFR 212.50(a))
Failure to develop written procedures (21 CFR 314.80(b))
Jun 13, 2013Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
input/output verification (21 CFR 211.68(b))
Written QA procedures established, followed (21 CFR 212.20(e))
Written specifications - components (21 CFR 212.40(b))
and 2 more
Jul 27, 2012Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Computer control of master formula records (21 CFR 211.68(b))
Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Written QA procedures established, followed (21 CFR 212.20(e))
and 6 more
Mar 8, 2012Voluntary Action Indicated (VAI)Investigator non-compliance (21 CFR 312.56(b))
Records of receipt, shipment, disposition (21 CFR 312.57(a))
General responsibilities of sponsors (21 CFR 312.50)
Notification of FDA of termination of investigator (21 CFR 312.56(b))
Jul 11, 2011Voluntary Action Indicated (VAI)No citations listed

Recalls

Showing the 10 most recent of 15 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 8, 2018Class IID-0609-2018E-Z-Paste Barium Sulfate Esophageal Cream (60% w/w), 454 g tube, Rx only, Manufactured by…
Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of…
May 27, 2015Class IIID-1147-2015E-Z-CAT Dry Barium Sulfate for Suspension (2% w/w after mixing), 23 g foil pouches, Rx…
Failed stability specifications:This recall has been initiated due to out of specification results for viscosity.
Sep 18, 2014Class IIID-0014-2015E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx…
Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.
Jul 2, 2014Class IIID-1536-2014E-Z-HD (barium sulfate) For Suspension (98% w/w), 340 g bottle, Rx Only, Manufactured by…
Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months.
Dec 16, 2013Class IIID-1083-2014VoLumen Barium Sulfate Suspension (0.1 % w/v, 0.1 ww/w), 450 mL bottle, Rx Only…
Failed Stability Testing: This product is below specification for preservative content.
Jul 19, 2013Class IIID-914-2013Tagitol V Barium Sulfate Suspension (40% w/v, 30% w/w) Net Contents: 20 mL, (NDC…
Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification…
Jun 21, 2013Class IID-885-2013Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organically…
Presence of foreign substance: One lot of the product may contain black foreign particles
Nov 21, 2012Class ID-157-2013Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100… and 1 more product
Presence of Particulate Matter; fibers identified as cellulose and polyvinyl
Aug 14, 2012Class IIID-095-2013Choletec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box…
Presence of Particulate Matter; potential for charcoal particulates
Jun 1, 2012Class IID-1684-2012CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile…
GMP deviation; Sr-82 levels exceeded alert limit specification

FDA record score

9 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

16 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAINov 27, 20246 x 16
Inspection classified VAIJun 5, 20176 x 0.251.5
Class II recall D-0609-2018, this FEI as the recalling firmMar 8, 20184 x 0.251
Inspection classified VAIMay 30, 201410 years or older, so it adds no points0
Class II recall D-885-2013, this FEI as the recalling firmJun 21, 201310 years or older, so it adds no points0
Inspection classified OAIJun 13, 201310 years or older, so it adds no points0
Class I recall D-157-2013, this FEI as the recalling firmNov 21, 201210 years or older, so it adds no points0
Inspection classified VAIJul 27, 201210 years or older, so it adds no points0
Class II recall D-1684-2012, this FEI as the recalling firmJun 1, 201210 years or older, so it adds no points0
Class II recall D-1665-2012, this FEI as the recalling firmApr 16, 201210 years or older, so it adds no points0
Inspection classified VAIMar 8, 201210 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsJan 31, 201210 years or older, so it adds no points0
Class II recall D-1115-2012, this FEI as the recalling firmSep 20, 201110 years or older, so it adds no points0
Class II recall D-866-2011, this FEI as the recalling firmJul 29, 201110 years or older, so it adds no points0
Inspection classified VAIJul 11, 201110 years or older, so it adds no points0
Class II recall D-033-4, this FEI as the recalling firmAug 7, 200310 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing BRACCO DIAGNOSTICS INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check BRACCO DIAGNOSTICS INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Bracco Diagnostics, Inc.
Location
Princeton, NJ (US)
Registration Expires
Dec 31, 2027
Operations
MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.